CD8+ T cells are a key population in the TIME for effective antitumor immunity because CD8+ T cells directly kill tumor cells by secreting effector cytokines (e.g., IFN-γ, TNF-α, and IL-2) (Hashimoto et al., 2018). This evidence concerns the gene IFNG and neoplasm.